AAAAAA
Results:
1-23
|
Results: 23
Authors:
Archer, DF
Citation: Df. Archer, The effect of the duration of progestin use on the occurrence of endometrial cancer in postmenopausal women, MENOPAUSE, 8(4), 2001, pp. 245-251
Authors:
Archer, DF
Citation: Df. Archer, Progestogen effects on coronary arteries: the need for definitive clinicaltrials, MENOPAUSE, 8(1), 2001, pp. 1-2
Authors:
Thiboutot, D
Archer, DF
Lemay, A
Washenik, K
Roberts, J
Harrison, DD
Citation: D. Thiboutot et al., A randomized, controlled trial of a low-dose contraceptive containing 20 mu g of ethinyl estradiol and 100 mu g of levonorgestrel for acne treatment, FERT STERIL, 76(3), 2001, pp. 461-468
Authors:
Archer, DF
Dorin, M
Lewis, V
Schneider, DL
Pickar, JH
Citation: Df. Archer et al., Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on endometrial bleeding, FERT STERIL, 75(6), 2001, pp. 1080-1087
Authors:
Archer, DF
Citation: Df. Archer, Contraception for the 21(st) century - Foreword, CLIN O GYNE, 44(1), 2001, pp. 60-61
Authors:
Archer, DF
Citation: Df. Archer, New contraceptive options, CLIN O GYNE, 44(1), 2001, pp. 122-126
Authors:
Archer, DF
Bush, T
Nachtigall, LE
Citation: Df. Archer et al., Re: Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin, J NAT CANC, 92(23), 2000, pp. 1950-1951
Authors:
Rebar, RW
Nachtigall, LE
Avis, NE
Kronenberg, F
Santoro, NF
Sowers, MF
Archer, DF
Citation: Rw. Rebar et al., Clinical challenges of perimenopause: Consensus opinion of the North American Menopause Society, MENOPAUSE, 7(1), 2000, pp. 5-13
Authors:
Charnock-Jones, DS
Macpherson, AM
Archer, DF
Leslie, S
Makkink, WK
Sharkey, AM
Smith, SK
Citation: Ds. Charnock-jones et al., The effect of progestins on vascular endothelial growth factor, oestrogen receptor and progesterone receptor immunoreactivity and endothelial cell density in human endometrium, HUM REPR, 15, 2000, pp. 85-95
Authors:
Archer, DF
Pickar, JH
Citation: Df. Archer et Jh. Pickar, Hormone replacement therapy: Effect of progestin dose and time since menopause on endometrial bleeding, OBSTET GYN, 96(6), 2000, pp. 899-905
Authors:
Kurman, RJ
Felix, JC
Archer, DF
Nanavati, N
Arce, JC
Moyer, DL
Citation: Rj. Kurman et al., Norethindrone acetate and estradiol-induced endometrial hyperplasia, OBSTET GYN, 96(3), 2000, pp. 373-379
Authors:
Tejedor, AG
Doncel, GF
Ballagh, SA
Archer, DF
Citation: Ag. Tejedor et al., Evaluation of human spermatozoa in cervical mucus: comparison of differentmicroscopic and extraction techniques, CONTRACEPT, 62(5), 2000, pp. 231-237
Authors:
Archer, DF
Lobo, RA
Land, HF
Pickar, JH
Citation: Df. Archer et al., A comparative study of transvaginal uterine ultrasound and endometrial biopsy for evaluating the endometrium of postmenopausal women taking hormone replacement therapy, MENOPAUSE, 6(3), 1999, pp. 201-208
Authors:
Macpherson, AM
Archer, DF
Leslie, S
Charnock-Jones, DS
Makkink, WK
Smith, SK
Citation: Am. Macpherson et al., The effect of etonogestrel on VEGF, oestrogen and progesterone receptor immunoreactivity and endothelial cell number in human endometrium, HUM REPR, 14(12), 1999, pp. 3080-3087
Authors:
Archer, DF
Furst, K
Tipping, D
Dain, MP
Vandepol, C
Citation: Df. Archer et al., A randomized comparison of continuous combined transdermal delivery of estradiol-norethindrone acetate and estradiol alone for menopause, OBSTET GYN, 94(4), 1999, pp. 498-503
Authors:
Archer, DF
Dorin, MH
Heine, W
Nanavati, N
Arce, JC
Citation: Df. Archer et al., Uterine bleeding in postmenopausal women on continuous therapy with estradiol and norethindrone acetate, OBSTET GYN, 94(3), 1999, pp. 323-329
Authors:
Archer, DF
Citation: Df. Archer, Endometrial histology during use of a low-dose estrogen-desogestrel oral contraceptive with a reduced hormone-free interval, CONTRACEPT, 60(3), 1999, pp. 151-154
Authors:
Mauck, CK
Callahan, MM
Baker, J
Arbogast, K
Veazey, R
Stock, R
Pan, ZY
Morrison, CS
Chen-Mok, M
Archer, DF
Gabelnick, HL
Citation: Ck. Mauck et al., The effect of one injection of Depo-Provera (R) on the human vaginal epithelium and cervical ectopy, CONTRACEPT, 60(1), 1999, pp. 15-24
Authors:
Archer, DF
DeSoto, KR
Baker, JM
Citation: Df. Archer et al., Interleukin-6 and tumor necrosis factor-alpha concentrations in the intrauterine cavity of postmenopausal women using an intrauterine delivery systemreleasing progesterone - A possible mechanism of action of the intrauterine device, CONTRACEPT, 59(3), 1999, pp. 175-179
Authors:
Archer, DF
Citation: Df. Archer, Guest Editorial - Alesse (R): Leading the shift to 20 mu g, AM J OBST G, 181(5), 1999, pp. S37-S38
Authors:
Archer, DF
Maheux, R
DelConte, A
O'Brien, FB
Citation: Df. Archer et al., Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 mu g levonorgestrel and 20 mu g ethinyl estradiol (Alesse (R)), AM J OBST G, 181(5), 1999, pp. S39-S44
Authors:
Archer, DF
Mammen, EF
Grubb, GS
Citation: Df. Archer et al., The effects of a low-dose monophasic preparation of levonorgestrel and ethinyl estradiol on coagulation and other hemostatic factors, AM J OBST G, 181(5), 1999, pp. S63-S66
Authors:
Utian, WH
Burry, KA
Archer, DF
Gallagher, JC
Boyett, RL
Guy, MP
Tachon, GJ
Chadha-Boreham, HK
Bouvet, AA
Citation: Wh. Utian et al., Efficacy and safety of low, standard, and high dosages of an estradiol transdermal system (Esclim) compared with placebo on vasomotor symptoms in highly symptomatic menopausal patients, AM J OBST G, 181(1), 1999, pp. 71-79
Risultati:
1-23
|